Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)

Milan · Healthcare · Drug Manufacturers - General
€52.75+0.00%As of 2026-11-22 · EUR
Last session low €52.75Last session high €52.95
52-week low €43.7652-week high €53.80
Market cap (USD)
$12.05B
Sector
Healthcare
P/E (TTM)
21.0x
Dividend yield
2.69%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-19 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in EUR.

IndicatorValueReading
RSI (14)53.3In the neutral range (30 to 70)
MACD (12, 26, 9)-0.02Below its signal line (0.00); histogram -0.01
Bollinger %B (20, 2)22%Inside the bands (52.60 to 53.27)
SMA 2052.93Price is 0.3% below
SMA 5052.88Price is 0.2% below
SMA 20050.64Price is 4.2% above
ATR (20)0.51% of priceAverage true range per day
52-week position90%In the upper part of the 43.76 to 53.80 range

About Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments.

Latest fiscal yearEnded 2025-12-31: revenue of 2.62B EUR and an operating margin of 27.5%.

More in Drug Manufacturers - General